NIT
FPRX

NumerixS Investment Technologies’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

NumerixS Investment Technologies’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-500
Closed -$8K – 1433
2018
Q2 		$8K Buy
+500
New +$8.72K ﹤0.01% 1065
2017
Q1 		– Sell
-2,300
Closed -$115K – 1454
2016
Q4 		$115K Sell
2,300
-5,000
-68% -$263K 0.01% 828
2016
Q3 		$383K Buy
7,300
+1,000
+16% +$47.8K 0.05% 459
2016
Q2 		$261K Buy
+6,300
New +$274K 0.04% 617

Other funds holding FPRX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

NumerixS Investment Technologies's FPRX Position: Q3 2018 in Review

NumerixS Investment Technologies sold out of Five Prime Therapeutics, Inc. (FPRX) in Q3 2018, closing a stake of 500 shares — an estimated $8K sold.

NumerixS Investment Technologies first reported a position in FPRX in Q2 2016 and held it in 4 quarters. The position peaked at $383K in Q3 2016. 114 funds tracked by Wall St. Rank hold FPRX as of Q3 2018.

  • NumerixS Investment Technologies reported no remaining Five Prime Therapeutics, Inc. position as of Q3 2018 after selling out during the quarter.
  • NumerixS Investment Technologies sold 500 Five Prime Therapeutics, Inc. shares in Q3 2018, an estimated $8K.
  • NumerixS Investment Technologies first reported a position in Five Prime Therapeutics, Inc. in Q2 2016 and held it in 4 quarters.
  • NumerixS Investment Technologies's Five Prime Therapeutics, Inc. position peaked at $383K in Q3 2016.
  • 114 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q3 2018.

Based on NumerixS Investment Technologies's 13F filing for Q3 2018, filed 13 Nov 2018.